The Role of Periodic Health Examination in Determining Indirect Muscle Injury Risk in Elite Football (Soccer)

NCT03782389 | Completed

• 1 other identifier: MUFC1
• Study Type: observational
• Target: 321
• Locations: 0 countries
• Sites: N/A

Brief Summary

Preseason periodic health examination (PHE) is used routinely in elite football (soccer) and can be used to inform injury prevention strategies. Indirect muscle injuries (IMI) are a considerable burden to elite teams. This investigation aims to evaluate whether measurements from PHE can be used in a multivariable model to predict IMI risk in elite players, or to establish prognostic factors that are associated with IMIs.

Conditions

Muscle Injury; Sprains and Strains

Keywords

Athlete; injury prevention; muscle strain; prediction; prognosis; screening; sport

Outcome Measures

Primary Outcomes (1)

• Number of participants with an indirect muscle injury.

  Indirect muscle injury defined according to Terminology and Classification of Muscle Injuries Consensus Statement

  11 Months (1 football season)

Secondary Outcomes (3)

• Number of participants with an indirect muscle injury affecting the hamstring muscle group.

  11 Months (1 football season)

• Number of participants with an indirect structural muscle injury.

  11 Months (1 football season)

• Number of participants with an indirect functional muscle injury.

  11 Months (1 football season)

Study Arms (1)

Elite football players aged 16-40 years

Other: Preseason Periodic Health Examination Completion

Interventions

Preseason Periodic Health Examination Completion OTHER

all available players completed a mandatory PHE on one of three days during the first week of the season. Typically, the musculoskeletal and performance components of the PHE included: 1) anthropometric measurements; 2) medical history (i.e. previous injury history); 3) musculoskeletal examination tests; 4) functional movement and balance tests; 5) strength and power tests.

Elite football players aged 16-40 years

Eligibility Criteria

• Age: 16 Years - 40 Years
• Sex: male
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

The population under study was of male elite football players aged 16-40 years old at an English Premier League club.

You may qualify if:

• had an outfield position (i.e. not a goalkeeper);
• participated in PHE testing for the relevant season.

You may not qualify if:

• \- if players were on trial or not contracted to the club at the time of PHE.

Sponsors & Collaborators

• Manchester United Football Club: lead
• University of Manchester: collaborator
• Keele University: collaborator
• Manchester Metropolitan University: collaborator

Related Publications (2)

• Hughes T, Riley R, Callaghan MJ, Sergeant JC. Can prognostic factors for indirect muscle injuries in elite football (soccer) players be identified using data from preseason screening? An exploratory analysis using routinely collected periodic health examination records. BMJ Open. 2023 Jan 24;13(1):e052772. doi: 10.1136/bmjopen-2021-052772.

  PMID: 36693686 DERIVED

• Hughes T, Riley RD, Callaghan MJ, Sergeant JC. The Value of Preseason Screening for Injury Prediction: The Development and Internal Validation of a Multivariable Prognostic Model to Predict Indirect Muscle Injury Risk in Elite Football (Soccer) Players. Sports Med Open. 2020 May 27;6(1):22. doi: 10.1186/s40798-020-00249-8.

  PMID: 32462372 DERIVED

MeSH Terms

Conditions

Sprains and Strains

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

• Richard Riley, PhD

  Centre for Prognosis Research, Keele University. UK

  STUDY DIRECTOR

• Jamie Sergeant, PhD

  Arthritis Research UK Centre for Epidemiology, University of Manchester. UK.

  STUDY DIRECTOR

• Michael Callaghan, PhD

  Dept of Health Professions, Manchester Metropolitan University. UK

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Senior Physiotherapist and Clinical Lead

Study Record Dates

• First Submitted: December 12, 2018
• First Posted: December 20, 2018
• Study Start: July 1, 2013
• Primary Completion: May 19, 2018
• Study Completion: May 19, 2018
• Last Updated: December 20, 2018

Record last verified: 2018-12

Data Sharing

• IPD Sharing: Will not share